Skip to content

AIP Medical: what changed

BE 0450.686.744NACE 46.460, Wholesale of pharmaceutical and medical goodsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€302,387
2024 · €241,361+€61,026
Equity
€1.1m
2024 · €1.0m+€75,910
Cash
€252,686
2024 · €277,610-€24,924
Balance sheet total
€1.6m
2024 · €1.4m+€277,787

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€275,655

    up €275,655 (+102%), from €270,551 to €546,206

    of which Trade receivables: +€185,825

  • Stocks and contracts +€36,698

    up €36,698 (+11.9%), from €308,073 to €344,771

  • Cash -€24,924

    down €24,924 (-9.0%), from €277,610 to €252,686

    mainly Receivables within one year (-€275,655) and Contributions, distributions and other (-€226,477)

  • Intangible fixed assets -€20,000

    down €20,000 (-44.6%), from €44,892 to €24,892

Equity and liabilities
  • Other debts +€200,000

    up €200,000 (+866%), from €23,100 to €223,100

  • Profit (loss) carried forward +€79,287

    up €79,287 (+10.0%), from €791,284 to €870,571

  • Debts after one year -€74,089

    down €74,089 (-60.0%), from €123,482 to €49,393

  • Tax, wage and social debts +€41,816

    up €41,816 (+50.3%), from €83,197 to €125,013

    of which Taxes: +€26,668

  • Trade debts +€32,184

    up €32,184 (+61.1%), from €52,711 to €84,895

Income statement
  • Gross operating margin +€120,443

    up €120,443 (+18.5%), from €652,617 to €773,060

  • Staff costs +€52,831

    up €52,831 (+23.0%), from €229,813 to €282,644

  • Taxes +€19,151

    up €19,151 (+22.4%), from €85,525 to €104,676

  • Other operating charges -€13,527

    down €13,527 (-51.2%), from €26,421 to €12,894

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €241,361
Gross operating margin +€120,443
Staff costs -€52,831
Depreciation -€4,576
Other operating charges +€13,527
Financial income -€691
Financial charges +€4,305
Taxes -€19,151
Result 2025 €302,387
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€329,416
Investment -€55,740
Financing -€298,600
Cash 2024 €277,610
Net result for the year +€302,387
Depreciation +€63,368
Stocks and contracts -€36,698
Receivables within one year -€275,655
Deferred charges and accrued income +€2,014
Trade debts +€32,184
Tax, wage and social debts +€41,816
Other debts +€200,000
Investment in fixed assets (net) -€55,740
Debts after one year -€74,089
Current portion of long-term debt +€1,966
Contributions, distributions and other -€226,477
Cash 2025 €252,686
brings cash intakes cash out
Every line side by side 51 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,360,346 €1,638,133 +€277,787 +20.4%
Fixed assets 21/28 €496,478 €488,850 -€7,628 -1.5%
Intangible fixed assets 21 €44,892 €24,892 -€20,000 -44.6%
Tangible fixed assets 22/27 €451,586 €463,958 +€12,372 +2.7%
Land and buildings 22 €421,801 €428,140 +€6,339 +1.5%
Plant, machinery and equipment 23 €16,947 €27,080 +€10,133 +59.8%
Furniture and vehicles 24 €12,838 €8,738 -€4,100 -31.9%
Current assets 29/58 €863,868 €1,149,283 +€285,415 +33.0%
Stocks and contracts in progress 3 €308,073 €344,771 +€36,698 +11.9%
Stocks 30/36 €308,073 €344,771 +€36,698 +11.9%
Amounts receivable within one year 40/41 €270,551 €546,206 +€275,655 +102%
Trade receivables 40 €116,511 €302,336 +€185,825 +159%
Other amounts receivable 41 €154,040 €243,870 +€89,830 +58.3%
Cash at bank and in hand 54/58 €277,610 €252,686 -€24,924 -9.0%
Deferred charges and accrued income 490/1 €7,634 €5,620 -€2,014 -26.4%
Total equity and liabilities 10/49 €1,360,346 €1,638,133 +€277,787 +20.4%
Equity 10/15 €1,005,733 €1,081,643 +€75,910 +7.5%
Contributions 10/11 €148,736 €148,736 = 0.0%
Capital 10 €148,736 €148,736 = 0.0%
Issued capital 100 €148,736 €148,736 = 0.0%
Reserves 13 €14,874 €14,874 = 0.0%
Non-distributable reserves 130/1 €14,874 €14,874 = 0.0%
Legal reserve 130 €14,874 - -€14,874
Reserves not available under the articles 1311 - €14,874 +€14,874
Profit (loss) carried forward 14 €791,284 €870,571 +€79,287 +10.0%
Investment grants 15 €50,839 €47,462 -€3,377 -6.6%
Amounts payable 17/49 €354,613 €556,490 +€201,877 +56.9%
Amounts payable after more than one year 17 €123,482 €49,393 -€74,089 -60.0%
Financial debts 170/4 €123,482 €49,393 -€74,089 -60.0%
Amounts payable within one year 42/48 €231,131 €507,097 +€275,966 +119%
Current portion of amounts payable after more than one year 42 €72,123 €74,089 +€1,966 +2.7%
Trade debts 44 €52,711 €84,895 +€32,184 +61.1%
Suppliers 440/4 €52,711 €84,895 +€32,184 +61.1%
Taxes, remuneration and social security 45 €83,197 €125,013 +€41,816 +50.3%
Taxes 450/3 €56,506 €83,174 +€26,668 +47.2%
Remuneration and social security 454/9 €26,691 €41,839 +€15,148 +56.8%
Other amounts payable 47/48 €23,100 €223,100 +€200,000 +866%
Non-recurring operating income 76A €5,741 - -€5,741
Remuneration, social security and pensions 62 €229,813 €282,644 +€52,831 +23.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €58,792 €63,368 +€4,576 +7.8%
Other operating charges 640/8 €26,421 €12,894 -€13,527 -51.2%
Gross operating margin 9900 €652,617 €773,060 +€120,443 +18.5%
Operating profit (loss) 9901 €337,591 €414,154 +€76,563 +22.7%
Financial income 75/76B €4,328 €3,637 -€691 -16.0%
Recurring financial income 75 €4,328 €3,637 -€691 -16.0%
Financial charges 65/66B €15,033 €10,728 -€4,305 -28.6%
Recurring financial charges 65 €15,033 €10,728 -€4,305 -28.6%
Profit (loss) for the period before taxes 9903 €326,886 €407,063 +€80,177 +24.5%
Income taxes 67/77 €85,525 €104,676 +€19,151 +22.4%
Profit (loss) for the period 9904 €241,361 €302,387 +€61,026 +25.3%
Profit (loss) for the period to be appropriated 9905 €241,361 €302,387 +€61,026 +25.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.4m to €1.7m

Midpoint €1.5m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Adjusted equity €1.1m
Capitalised earnings €1.7m to €2.4m
Indication €1.4m to €1.7m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,081,643
Intangible fixed assets (21)
-€24,892
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.1m

Capitalised earnings

net result for the year (9904)
2025
€302,387
2024
€241,361
excluding non-recurring income and charges
€235,620
2023
€193,692
2022
€97,025
excluding non-recurring income and charges
€100,834
2021
€74,411
Average result, excluding non-recurring income and charges
€243,900
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.7m / €2.0m / €2.4m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 11 November 2026 via checked.be.